10-K: Quoin Pharmaceuticals Details Share Structure and Regulatory Compliance in Annual Filing

Quoin Pharmaceuticals' annual report on Form 10-K provides a detailed overview of the company's share structure, voting rights, and compliance with securities regulations.

Summary

• Quoin Pharmaceuticals, an Israeli company, has registered American Depositary Shares (ADSs), each representing one ordinary share, under the Securities Exchange Act of 1934.
• As of December 31, 2023, the company had 100,000,000 authorized ordinary shares, with 987,220 ordinary shares and 987,220 ADSs outstanding.
• Holders of ordinary shares have one vote per share on all matters submitted to a shareholder vote.
• The company's articles of association allow for increases or reductions in share capital, subject to shareholder approval and the provisions of the Israeli Companies Law.
• Dividend distributions are determined by the board of directors and do not require shareholder approval, unless the company does not meet certain financial criteria.
• The company is required to hold an annual general meeting of shareholders once every calendar year, no later than 15 months after the previous annual meeting.
• A quorum for general meetings requires at least 25% of the total outstanding voting rights, but the board intends to amend this to 33.33%.
• The company's ordinary shares are freely transferable, except as restricted by applicable law or stock exchange rules.
• The company's ADSs are administered by The Bank of New York Mellon, and ADS holders have rights as defined in the deposit agreement.
• The depositary will distribute dividends and other distributions to ADS holders in proportion to the number of ordinary shares their ADSs represent, after deducting fees and expenses.
• ADS holders may instruct the depositary how to vote the ordinary shares their ADSs represent, but the depositary is not responsible for failing to carry out voting instructions.
• The depositary may collect fees for delivery and surrender of ADSs, distributions, and depositary services.
• The deposit agreement can be amended by the company and the depositary without consent of the ADS holders, but amendments that add or increase fees or prejudice a substantial right of ADS holders will not become effective for 30 days after notification.
• The deposit agreement can be terminated by the depositary if the company instructs it to do so, or under certain other conditions, such as delisting or insolvency.

Sentiment

Score: 7

Explanation: The document is factual and descriptive, providing necessary information about the company's share structure and regulatory compliance. It does not contain any significant positive or negative sentiment, but the information is essential for investors.

Positives

• The company's ordinary shares are freely transferable, except as restricted by applicable law or stock exchange rules.
• The depositary will distribute dividends and other distributions to ADS holders in proportion to the number of ordinary shares their ADSs represent, after deducting fees and expenses.
• ADS holders may instruct the depositary how to vote the ordinary shares their ADSs represent.

Negatives

• The depositary is not responsible for failing to carry out voting instructions.
• The deposit agreement can be amended by the company and the depositary without consent of the ADS holders, but amendments that add or increase fees or prejudice a substantial right of ADS holders will not become effective for 30 days after notification.
• The deposit agreement can be terminated by the depositary if the company instructs it to do so, or under certain other conditions, such as delisting or insolvency.

Risks

• The company's articles of association allow for changes in share capital, subject to shareholder approval and the provisions of the Israeli Companies Law.
• Dividend distributions are determined by the board of directors and do not require shareholder approval, unless the company does not meet certain financial criteria.
• The depositary is not responsible for failing to carry out voting instructions.
• The deposit agreement can be amended by the company and the depositary without consent of the ADS holders, but amendments that add or increase fees or prejudice a substantial right of ADS holders will not become effective for 30 days after notification.
• The deposit agreement can be terminated by the depositary if the company instructs it to do so, or under certain other conditions, such as delisting or insolvency.

Future Outlook

The company intends to place the adoption of an amendment to the quorum requirements in its articles of association on the agenda of its next annual general meeting of shareholders.

Industry Context

This document provides a foundational understanding of Quoin Pharmaceuticals' share structure and regulatory compliance, which is essential for investors and stakeholders in the pharmaceutical industry.

Comparison to Industry Standards

• The structure of Quoin Pharmaceuticals' share capital and voting rights is typical for a publicly traded company, with one vote per share.
• The use of American Depositary Shares (ADSs) to represent ordinary shares is a common practice for international companies listed on U.S. stock exchanges, similar to companies like Teva Pharmaceuticals and Check Point Software Technologies.
• The deposit agreement between Quoin, the depositary, and ADS holders is a standard arrangement, similar to those used by other companies with ADSs, such as BioNTech and AstraZeneca.
• The provisions for amending and terminating the deposit agreement are also typical, providing flexibility for the company and the depositary while protecting the rights of ADS holders, similar to the arrangements of companies like Novartis and Roche.
• The requirement for shareholder approval for changes in share capital and certain other matters is consistent with corporate governance standards in many jurisdictions, including Israel, similar to companies like Wix.com and Amdocs.

Corporate Governance

Stakeholder Impact

• Shareholders: The document provides information about their voting rights, dividend rights, and the transferability of their shares.
• ADS Holders: The document outlines their rights and how they receive distributions and exercise voting rights.
• Creditors: The document mentions that the company must ensure that dividend distributions do not prevent it from satisfying its obligations to creditors.

Next Steps

• The board intends to place the adoption of an amendment to the quorum requirements in its articles of association on the agenda of its next annual general meeting of shareholders.

Key Dates

Keywords

American Depositary Shares, Ordinary Shares, Share Capital, Voting Rights, Dividends, Shareholders Meetings, Israeli Companies Law, Deposit Agreement, ADS Holders, Depositary